NERATINIB CRYSTALLINE FORMS AND PROCESS FOR PREPARATION THEREOF

The present invention relates to novel crystalline forms of Neratinib and processes for preparation thereof. Neratinib is a tyrosine kinase inhibitor formula (I), having the chemical name (2E)-N-[4-[[3-Chloro-4-[(pyridin-2-yl)methoxy]phenyl]amino]-3-cyano- 7-ethoxyquinolin-6-yl]-4-(dimethylamino)but...

Ausführliche Beschreibung

Bibliographische Detailangaben

Hauptverfasser:	SHIVDAVKAR, Radhakrishna, SIYAN, Rajinder, BHISE, Nandu, SANPHUI, Palash, SADAPHAL, Vikas, SULAKE, Rohidas, SINGH, Girij
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS METALLURGY ORGANIC CHEMISTRY
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!